Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Net Margin (2019 - 2025)

Eton Pharmaceuticals' Net Margin history spans 7 years, with the latest figure at 6.97% for Q4 2025.

  • On a quarterly basis, Net Margin rose 1210.0% to 6.97% in Q4 2025 year-over-year; TTM through Dec 2025 was 7.14%, a 266.0% increase, with the full-year FY2025 number at 5.75%, up 404.0% from a year prior.
  • Net Margin hit 6.97% in Q4 2025 for Eton Pharmaceuticals, up from 8.58% in the prior quarter.
  • Over the last five years, Net Margin for ETON hit a ceiling of 43.0% in Q1 2021 and a floor of 786.32% in Q3 2021.
  • Historically, Net Margin has averaged 66.3% across 5 years, with a median of 9.38% in 2024.
  • The widest YoY moves for Net Margin: up 2358427bps in 2021, down -25621628bps in 2021.
  • Tracing ETON's Net Margin over 5 years: stood at 17.05% in 2021, then plummeted by -37bps to 10.73% in 2022, then crashed by -171bps to 7.57% in 2023, then surged by 32bps to 5.13% in 2024, then soared by 236bps to 6.97% in 2025.
  • Business Quant data shows Net Margin for ETON at 6.97% in Q4 2025, 8.58% in Q3 2025, and 13.66% in Q2 2025.